Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.
Clinical trial NCT04229459 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04229459
- Sponsor
- Baruch Brenner
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-16
- Primary completion
- 2022-10-12
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.